REFERENCES
- O'Brien RJ, Geiter LJ, Snider DE, The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135: 1007–1014.
- Engbaek HC, Vergmann B, Baess I, Will DW. M. xenopei A bacteriological study of M xenopei including case reports of Danish patients. Acta Pathol Microbiol Immunol Scand 1967; 69: 576–594.
- Beck A, Stanford JL. Mycobacterium xenopei: a study of sixteen strains. Tubercle 1968; 49: 226–234.
- Bretey J, Boisvert H. Mycobacterium xenopei, agent d'af-fections pulmonaires et “contaminant”. Rev Tuberc Pneumol 1969; 33: 337–348.
- Tortoli E, Simonetti MT, Labardi C, et al. Mycobacteri-um xenopi isolation from clinical specimens in the Florence area: review of 46 cases. Eur J Epidemiol 1991; 7: 677-681. Costrini AM, Mahler DA, Gross WH, Hawkins JE, Yesner R, D'Esopo ND. Clinical and roentgenographic fea-tures of nosocomial pulmonary disease due to Mycobacterium xenopi Am Rev Respir Dis 1981; 123: 104–109.
- Thomas P, Liu P, Weiser W. Caracteristiques de la patologie par Mycobacterium xenopi. Bull Int Union Tuberc Lung Dis 1988; 63: 12–13.
- Simor AE, Salit IE, Vellend H. The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis 1984; 129: 435–438.
- Doyle W, Evander LC, Gruft H. Pulmonary disease caused by Mycobacterium xenopei. Am Rev Respir Dis 1968; 97: 919–922.
- Ausina V, Barrio J, Luquin M, et al. Mycobacterium xenopi infections in the acquired immunodeficiency syn-drome. [letter]. Ann Intern Med 1988; 109: 927–928.
- Eng RHK, Forrester C, Smith SM, Sobel H. Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest 1984; 86: 145–147.
- Tecson-Tumang FT, Bright JL. Mycobacterium xenopi and the acquired immunodeficiency syndrome. [letter]. Ann Intern Med 1984; 100: 461–462.
- Heifets L, Lindholm-Levy P, Libonati J, et al. Radiometric broth macrodilution method for determination of minimal inhibitory concentrations (MIC) with Mycobacterium avium complex isolates. Denver: National Jewish Center for Immunology and Respiratory Medicine, 1993: 23.
- Rastogi N, Goh KS, Guillou N, Labrousse V. Spectrum of drugs against atypical mycobacteria. How valid is the current practice of drug susceptibility testing and the choice of drugs? Zentralbl Bakteriol-Int J Med Microbiol 1992; 277: 474–484.
- Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis 1988; 137: 1217–1222.
- Siddiqi SH, Heifets LB, Cynamon MH, et al. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol 1993; 31: 2332–2338.
- Smith MJ, Citron KM. Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax 1983; 38: 373–377.
- Hoffner SE, Kallenius G, Beezer AE, Svenson SB. Studies on the mechanisms of the synergistic effect of etham-butol and other antibacterial drugs on Mycobacterium avium complex. Acta Leprol 1989; 7 (Suppl. 1): 195-199.
- Hoffner SE, Hje1m U, Kallenius G. Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrob Agents Chemother 1993; 37: 1285–1288.